AUROTON Trademark

Trademark Overview

On Thursday, March 30, 2023, a trademark application was filed for AUROTON with the United States Patent and Trademark Office. The USPTO has given the AUROTON trademark a serial number of 97864367. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, April 14, 2026. This trademark is owned by Rubicon Research Private Limited. The AUROTON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for prevention and treatment of anxiety, depression, hypertension, cardiovascular disorders, sleep disorders, psychotic conditions, attention-deficit hyperactivity disorder, diabetes, Parkinson's disease; Medicinal Preparations for prevention and treatment of anxiety, depression, hypertension, cardiovascular disorders, sleep disorders, psychotic conditions, attention-deficit hyperactivity disorder, diabetes, Parkinson's disease
auroton

General Information

Serial Number97864367
Word MarkAUROTON
Filing DateThursday, March 30, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, April 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for prevention and treatment of anxiety, depression, hypertension, cardiovascular disorders, sleep disorders, psychotic conditions, attention-deficit hyperactivity disorder, diabetes, Parkinson's disease; Medicinal Preparations for prevention and treatment of anxiety, depression, hypertension, cardiovascular disorders, sleep disorders, psychotic conditions, attention-deficit hyperactivity disorder, diabetes, Parkinson's disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, April 23, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRubicon Research Private Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressMaharashtra 400604
IN

Trademark Events

Event DateEvent Description
Monday, April 3, 2023NEW APPLICATION ENTERED
Sunday, April 23, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 26, 2023ASSIGNED TO EXAMINER
Tuesday, January 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 5, 2024SUSPENSION LETTER WRITTEN
Friday, April 5, 2024LETTER OF SUSPENSION E-MAILED
Friday, April 5, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 6, 2025SUSPENSION INQUIRY WRITTEN
Monday, January 6, 2025INQUIRY TO SUSPENSION E-MAILED
Monday, January 6, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, April 7, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, April 25, 2025ASSIGNED TO LIE
Friday, April 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 28, 2025SUSPENSION LETTER WRITTEN
Monday, April 28, 2025LETTER OF SUSPENSION E-MAILED
Monday, April 28, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 5, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, January 13, 2026SUSPENSION INQUIRY WRITTEN
Tuesday, January 13, 2026INQUIRY TO SUSPENSION E-MAILED
Tuesday, January 13, 2026NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, April 13, 2026TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, April 14, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 14, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 14, 2026SUSPENSION LETTER WRITTEN
Tuesday, April 14, 2026LETTER OF SUSPENSION E-MAILED
Tuesday, April 14, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

auroton disorders deficit attention hyperactivity conditions disorder disease parkinson diabetes psychotic